doxepin has been researched along with Agoraphobia in 4 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| "50 patients with panic disorder (30 without and 20 with concomitant depression) were enrolled in a controlled treatment study using either imipramine or doxepin in addition to supportive psychotherapy and were then studied under naturalistic treatment conditions over a 5-year period." | 5.08 | Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up. ( Albus, M; Scheibe, G; Scherer, J, 1995) |
| "After controlled treatment with either imipramine or doxepin with additional psychotherapy, 30 patients with pure panic disorder and 20 with concomitant depression were followed under ordinary treatment conditions over a 5-year period." | 5.08 | Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up. ( Albus, M; Scheibe, G; Scherer, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albus, M | 3 |
| Scheibe, G | 3 |
| Scherer, J | 2 |
| Zarate, R | 1 |
| Craske, MG | 1 |
| Barlow, DH | 1 |
3 trials available for doxepin and Agoraphobia
| Article | Year |
|---|---|
Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
Topics: Adult; Agoraphobia; Combined Modality Therapy; Comorbidity; Depressive Disorder; Doxepin; Female; Fo | 1995 |
Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Doxepin; Follow-Up | 1995 |
Predictors of outcome in panic disorder: a 5-year prospective follow-up study.
Topics: Adolescent; Adult; Agoraphobia; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Doxepin | 1996 |
1 other study available for doxepin and Agoraphobia
| Article | Year |
|---|---|
Situational exposure treatment versus panic control treatment for agoraphobia. A case study.
Topics: Adaptation, Psychological; Adult; Agoraphobia; Alprazolam; Arousal; Behavior Therapy; Combined Modal | 1990 |